tiprankstipranks
Inovio Pharmaceuticals (INO)
NASDAQ:INO
US Market
INO
Inovio Pharmaceuticals
RESEARCH TOOLSreports
Want to see INO full AI Analyst Report?

Inovio Pharmaceuticals (INO) Income Statement

5,977 Followers

Inovio Pharmaceuticals Income Statement

Last quarter (Q4 2025), Inovio Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Inovio Pharmaceuticals's net income was $3.76M. See Inovio Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 65.34K$ 217.76K$ 832.01K$ 10.26M$ 1.77M
Gross Profit
$ 65.34K$ 217.76K$ 832.01K$ 10.26M$ 1.77M
Operating Expenses
$ 86.89M$ 112.62M$ 144.77M$ 277.84M$ 302.99M
Depreciation and Amortization
$ 2.99M$ 3.13M$ 3.50M$ 5.50M$ 4.73M
EBITDA
$ -81.96M$ -103.95M$ -130.39M$ -270.90M$ -296.56M
Operating Income
$ -86.82M$ -112.40M$ -143.94M$ -267.57M$ -301.22M
Other Income/Expenses
$ 1.88M$ 5.14M$ 8.82M$ -12.24M$ -2.44M
Pretax Income
$ -84.95M$ -107.25M$ -135.12M$ -279.82M$ -303.66M
Net Income
$ -84.95M$ -107.25M$ -135.12M$ -279.82M$ -303.66M
Per Share Metrics
Basic EPS
$ -1.81$ -3.95$ -6.09$ -14.07$ -1.42
Diluted EPS
$ -1.81$ -3.95$ -6.09$ -14.07$ -1.42
Weighted Average Shares Outstanding
 468.86M 27.16M 22.17M 19.89M 214.62M
Weighted Average Shares Outstanding (Diluted)
 468.86M 27.16M 22.17M 19.89M 214.62M
Currency in USD

Inovio Pharmaceuticals Earnings and Revenue History